A carregar...
Expected population impacts of discontinued prostate-specific antigen screening
BACKGROUND: Prostate-specific antigen (PSA) screening for prostate cancer has high risks of overdiagnosis, particularly in older men, and reports from screening trials indicate that it saves few lives after 11–13 years of follow-up. New clinical guidelines recommend against PSA screening for all men...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221407/ https://ncbi.nlm.nih.gov/pubmed/25065910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28932 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|